Search for: "Risk v. Wells Market Service, Inc." Results 861 - 880 of 1,030
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Mar 2020, 4:59 am by Chris Wesner
Her twin goals were “becoming the bridge between the American market and the Hispanic market” and “building a career as an entrepreneur. [read post]
28 Jul 2016, 12:59 pm by Rebecca Tushnet
Florida International University Board of Trustees v. [read post]
4 Dec 2013, 11:04 am by Rebecca Tushnet
National Awards Service Advisory, 2012—tricked people into paying $20 to claim the alleged prize. [read post]
25 Feb 2014, 10:02 am by Justin Bagdady
”  Brenner added that this provision could thus “fill a gap” caused by the Supreme Court’s decision in Janus Capital Inc. v. [read post]
20 Mar 2012, 7:42 am by Cynthia Marcotte Stamer
  Taking time to make changes needed to identify and resolve potential conflicts and other ambiguities between required terms of the SBC and Glossary and existing health plan documentation, communications and procedures is particularly important in light of the United States Supreme Court’s May 16, 2011 ruling in Cigna Corp. v. [read post]
4 Jan 2021, 1:26 pm by Kevin LaCroix
It is also hard to know what the lulls imply as far as future filing patterns as we head into 2021, as well. [read post]
15 Jan 2023, 4:05 pm by INFORRM
International – Compagnia Generale Distribuzione s.p.a. v Zorro Productions Inc). [read post]
6 Feb 2012, 5:08 am by Max Kennerly, Esq.
As I have mentioned before, the primary impetus behind a contingency fee agreement is risk. [read post]
18 Feb 2012, 5:15 am by Richard Renner
Instead, Lawson and Zang worked either for FMR LLC or one of its subsidiaries, Fidelity Brokerage Services, LLC. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
5 Apr 2012, 11:27 am by Joe Consumer
Chamber of Commerce 2008) and punitive damages have been perceived as so problematical as to lead the Supreme Court to impose constitutional limits, using controversial substantive due process principles, as well as federal statutory limits (BMW of North America, Inc. v. [read post]
5 Apr 2012, 11:27 am by Joe Consumer
Chamber of Commerce 2008) and punitive damages have been perceived as so problematical as to lead the Supreme Court to impose constitutional limits, using controversial substantive due process principles, as well as federal statutory limits (BMW of North America, Inc. v. [read post]